1494 related articles for article (PubMed ID: 11850611)
1. The use of antithrombotic drugs in older people.
Tufano A; Cerbone AM; Di Minno G
Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG).
Di Minno G; Tufano A; Cerbone AM
Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):41-62. PubMed ID: 11383324
[TBL] [Abstract][Full Text] [Related]
3. State of the art--a journey through the world of antithrombotic therapy.
Turpie AG
Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():3-11. PubMed ID: 12232817
[TBL] [Abstract][Full Text] [Related]
4. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
[TBL] [Abstract][Full Text] [Related]
5. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic drugs in vascular medicine: a historical perspective.
Schrör K
Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
[TBL] [Abstract][Full Text] [Related]
7. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
Arjomand H; Cohen M; Ezekowitz MD
J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation and anticoagulation.
Garnier LF; Rouesnel P; Espitalier F
Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
[TBL] [Abstract][Full Text] [Related]
9. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
10. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
11. ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
Gabriel RS; White HD
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):851-7. PubMed ID: 17867915
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting.
Shennib H; Endo M; Benhameid O
Heart Surg Forum; 2003; 6(5):288-91. PubMed ID: 14721795
[TBL] [Abstract][Full Text] [Related]
13. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
14. Successors to heparin: new antithrombotic agents.
Turpie AG
Am Heart J; 1997 Nov; 134(5 Pt 2):S71-7. PubMed ID: 9396637
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic drugs for the secondary prevention of ischemic stroke.
Nenci GG; Goracci S
Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
Poredos P; Jezovnik MK
Int Angiol; 2010 Feb; 29(1):20-6. PubMed ID: 20224527
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury.
Vergouwen MD; Roos YB; Kamphuisen PW
Curr Opin Crit Care; 2008 Apr; 14(2):149-55. PubMed ID: 18388676
[TBL] [Abstract][Full Text] [Related]
18. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
20. Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
Nutescu EA; Wittkowsky AK; Dobesh PP; Hawkins DW; Dager WE
Ann Pharmacother; 2006 Sep; 40(9):1558-71. PubMed ID: 16912250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]